Abbonarsi

Prevalence, incidence and prognostic implications of left bundle branch block in patients with stable coronary artery disease. An analysis from the CLARIFY registry - 06/01/20

Doi : 10.1016/j.acvdsp.2019.09.235 
A. Darmon 1, , G. Ducrocq 1, Y. Elbez 1, E. Sorbets 2, R. Ferrari 3, I. Ford 4, J.C. Tardif 5, M. Tendera 6, K.M. Fox 7, P.G. Steg 1
1 Cardiologie, Hopital Bichat, Paris 
2 92, Hopital Avicenne, Bobigny, France 
3 Department of Cardiology, Maria Cecilia Hospital, Department of Cardiology and LTTA Centre, University Hospital of Ferrara and Maria Cecilia Hospital, Cotignola, Italy 
4 University of Glasgow, Robertson Centre for Biostatistics, Glasgow, United Kingdom of Great Britain & Northern Ireland 
5 Montreal Heart Institute, University of Montreal, Montreal, Canada 
6 Medical University of Silesia, Katowice, Poland 
7 Royal Brompton Hospital, NHLI Imperial College, ICMS, London, United Kingdom of Great Britain & Northern Ireland 

Corresponding author.

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
Articolo gratuito.

Si connetta per beneficiarne

Riassunto

Background

The prevalence, and prognostic implication of left bundle branch block (LBBB) patients with stable coronary artery disease (CAD) is unknown.

Purpose

To describe the prevalence, incidence and prognostic implications of LBBB in patients with stable CAD.

Methods

CLARIFY is an international registry of more than 30.000 patients with stable CAD. LBBB was defined as a QRS complex>120 milliseconds. Patients with previous pacemaker implantation or defibrillator were excluded. The primary outcome was a composite of cardiovascular (CV) Death, MI or stroke, and secondary outcomes included hospitalization for heart failure (HF) or the need for pacemaker implantation.

Results

From the 23.457 patients with available data, 1.041 (4.4%) had LBBB at baseline and 1.237 (5.3%) during 5-year follow-up. Only 21 patients with newly diagnosed LBBB overtime, had a documented MI the same year. Compared to patients without LBBB, patients with LBBB had a higher risk profile regarding age (67.2±10.1 versus 63.6±10.4 years, P<0.0001), history of coronary artery bypass grafting (29.2% vs. 23.7%, P<0.0001), diabetes (35.1% vs. 28.4%, P<0.0001), and HF (25.2% vs. 16.8%, P<0.0001). In multivariate analysis there was no difference in the rate of primary outcome between LBBB or no-LBBB patients (adjusted HR 1.04, 95% CI 0.85–1.29). Patients with LBBB had a higher rate of pacemaker implantation (adjusted HR 2.21, 95% CI 1.55–3.15, P<0.0001) and hospitalization for HF (adjusted HR 1.53, 95% CI 1.25–1.88, P<0.0001) (Table 1, Fig. 1).

Conclusion

The prevalence of LBBB in patients with stable CAD was 4.4% and 5.3% with 5-year follow-up. The majority of newly diagnosed LBBB were not contemporary of myocardial infarction. LBBB was not associated with a higher rate of major adverse cardiovascular events, but with a higher risk of pacemaker implantation and hospitalization for heart failure. This is the first study reporting such results in a broad population of stable CAD patients.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2019  Pubblicato da Elsevier Masson SAS.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 12 - N° 1

P. 107-108 - gennaio 2020 Ritorno al numero
Articolo precedente Articolo precedente
  • Primary prevention of sudden cardiac death in patients with tetralogy of Fallot with implantable cardioverter defibrillator: Insights from the DAI-T4F study
  • V. Waldmann, A. Bouzeman, F. Bessiere, F. Labombarda, M. Ladouceur, C. Marquié, C. Guenancia, C. Audinet, P. Defaye, A. Mathiron, C. Walton, P. Winum, P. Bru, B. Guy-Moyat, Y. Bernard, L. Iserin, J.B. Thambo, J.L. Pasquié, N. Combes, E. Marijon
| Articolo seguente Articolo seguente
  • Epicardial atrial fat and left atrium remodeling
  • A. Felder, M. Kibler, S. El Ghannudi-Abdo, P. Ohlmann, O. Morel, L. Jesel

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.